{
    "organizations": [],
    "uuid": "d8ebf965c01a046d2a4a333a48a6e5e74663179f",
    "author": "",
    "url": "https://www.reuters.com/article/brief-msd-animal-health-gets-positive-op/brief-msd-animal-health-gets-positive-opinion-from-european-medicines-agency-for-bravecto-plus-idUSASO0002BT",
    "ord_in_thread": 0,
    "title": "BRIEF-MSD Animal Health Gets Positive Opinion From European Medicines Agency For Bravecto Plus",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 07 PM / Updated 12 minutes ago BRIEF-MSD Animal Health Gets Positive Opinion From European Medicines Agency For Bravecto Plus Reuters Staff 1 Min Read March 21 (Reuters) - Merck & Co Inc: * MSD ANIMAL HEALTH RECEIVES POSITIVE OPINION FROM EUROPEAN MEDICINES AGENCY FOR BRAVECTOÂ® PLUS (FLURALANER PLUS MOXIDECTIN) SPOT-ON SOLUTION FOR CATS Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)",
    "published": "2018-03-21T14:07:00.000+02:00",
    "crawled": "2018-03-21T14:29:25.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "animal",
        "health",
        "get",
        "positive",
        "opinion",
        "european",
        "medicine",
        "agency",
        "bravecto",
        "plus",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "merck",
        "co",
        "inc",
        "msd",
        "animal",
        "health",
        "receives",
        "positive",
        "opinion",
        "european",
        "medicine",
        "agency",
        "plus",
        "fluralaner",
        "plus",
        "moxidectin",
        "solution",
        "cat",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "bengaluru",
        "newsroom"
    ]
}